The first half of 2020 saw the advent of coronavirus disease 2019 (COVID-19) as a pandemic, which had an immediate and significant impact on cancer care. The COVID-19 pandemic has had a wide-ranging detrimental effect on cancer care, with variable degrees of severity in different places throughout the world. Patients with cancer are a vulnerable population, and they are exposed to a variety of problems during pandemics, including infection susceptibility and disruption of their cancer or regular medical care. Potential cardiovascular complications in cancer patients who have also been infected with SARS-CoV-2 are one of the most pressing concerns for clinicians. The renin-angiotensin-aldosterone system (RAAS) is another area of concern in COVID-19 positive cancer patients.
Important Alert:
X
Title : Deubiquitylase USP31 induces autophagy and promotes the progression in lung squamous cell carcinoma cells by stabilizing E2F1 expression
Qian Zhang, The Affiliated Changzhou Second People’s Hospital of Nanjing Medical University, China
Title :
Luca Roncati, University of Modena and Reggio Emilia, Italy
Title :
Bene Ekine-Afolabi, ZEAB Therapeutic Ltd, United Kingdom
Title :
K.P.Mishra, Asian Association for Radiation Research, India